We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Explore
Metastatic Breast Cancer
Center of Excellence
Interested in receiving weekly updates about the Metastatic Breast Cancer Center of Excellence?
You can find your saved items on your dashboard, in the "saved" tab.
You've recommended your first item
Your recommendations help us improve our content suggestions for you and other PracticeUpdate members.
You've subscribed to your first topic alert
What does that mean?
Each day, we'll check to see if new items have been published to the topics you're subscribed to, and we'll send you one email with all of the new items from that day.
We'll keep all topic alert notifications available on your dashboard for 30 days, to make sure you don't miss anything.
Lastly, whenever you have unread items in the topics you've subscribed to, the "Alerts" icon will light up in the main menu. Just click on the bell to see your five most-recent, unread notifications.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
No comments yet, be the first to start the discussion!
heba abusin
Nov 19, 2018
Before decision regarding SLND, what is the metastatic work up and KI67, chronic diseases and PS ?
N Cul
Nov 23, 2018
Not necessary,as cancer may be in lungs or viseral. CT or MRI more useful.
surapong supaporn
Nov 23, 2018
Adjuvant aromatase inhibitor if luminalA..tamoxifen is contraindicated
21 recurrent score might be beneficial for decision making about chemo therapy
69 years old may not need alnd but radiation therapy to whole breast and regional nodes
Alnd is still an option
DANIEL CAMPOS
Nov 23, 2018
I would start hormone treatment with aromatase inhibitor identifying a measurable lesion to evaluate response. After 90 days of medication and attending especially the evolution of his thromboembolic disease, I would think about the locoregional actinic treatment if I have response. I do not see any usefulness of the ALND.
Was it enough to have targeted axillary lymph node dissection only?
Jayaprakash Madhavan
Nov 24, 2018
She has ER +ve HER2 _ve T2 N1 disease.Being a luminal A type ALD may be avoided. She needs adj AI.she may be candidate for adjuvant radiation as 3 LN are
+ VE ONE with ene
JOSE FERNANDO ROBLEDO
Nov 25, 2018
Given that a metastatic lymph node was proven positive upfront she would not qualify por Z0011 or Amaros trials. I think she had an indication por lumpectomy + lymph node dissection or to enrole in a neoadjuvant primary systemic therapy trial like the Alliance
Samaneh Sarbaz
Nov 29, 2018
First of all,PS,metastatic work up and ki67 are necessary
Dec 23, 2024
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.
heba abusin
Nov 19, 2018
N Cul
Nov 23, 2018
surapong supaporn
Nov 23, 2018
DANIEL CAMPOS
Nov 23, 2018
[email protected] [email protected]
Nov 24, 2018
Jayaprakash Madhavan
Nov 24, 2018
JOSE FERNANDO ROBLEDO
Nov 25, 2018
Samaneh Sarbaz
Nov 29, 2018
Dec 23, 2024
Pending Moderator approval.